Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

In a study on ovarian cancer cells, researchers from Karolinska Institutet ... Ph.D. student at the Department of Oncology-Pathology, Karolinska Institutet, and the study's first author.

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...

Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can ...

To optimize treatment outcomes for patients whose late-stage cancer shows resistance to the standard treatment, Sarasota Memorial Research Institute will participate in testing an experimental ...

A comparison of patients with and without BRCA gene mutations receiving prophylactic risk-reduction surgery suggest ...

A second phase 1 trial plans to evaluate CER-1236, a novel chimeric antigen receptor therapy, for solid tumors.

This is because it specifically targets the cancer cells, which reduces the side effects seen with more conventional therapies. Tumours, such as some breast and ovarian cancers, can express the ...